Drug combination may improve impact of immunotherapy in head and neck cancer – EurekAlert (press release)
EurekAlert (press release) |
Drug combination may improve impact of immunotherapy in head and neck cancer
EurekAlert (press release) Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers may have found a way to … The big question: Will cancer immune therapy work for me? [Combination Therapy of Immune Checkpoint Inhibitors]. |
